Champions Oncology Inc (CSBR) - Total Liabilities
Based on the latest financial reports, Champions Oncology Inc (CSBR) has total liabilities worth $24.07 Million USD as of January 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Champions Oncology Inc cash flow conversion to assess how effectively this company generates cash.
Champions Oncology Inc - Total Liabilities Trend (1996–2025)
This chart illustrates how Champions Oncology Inc's total liabilities have evolved over time, based on quarterly financial data. Check Champions Oncology Inc asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Champions Oncology Inc Competitors by Total Liabilities
The table below lists competitors of Champions Oncology Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Progress-Werk Oberkirch AG
XETRA:PWO
|
Germany | €271.95 Million |
|
Space Shuttle Hi-Tech Co Ltd
TW:2440
|
Taiwan | NT$1.28 Billion |
|
Cryomax Cooling System Corp
TW:1587
|
Taiwan | NT$2.14 Billion |
|
Taeyang Metal
KO:004100
|
Korea | ₩432.99 Billion |
|
DreamCIS Inc
KQ:223250
|
Korea | ₩60.03 Billion |
|
Nevada King Gold Corp
V:NKG
|
Canada | CA$86.64K |
|
Rock Tech Lithium Inc
V:RCK
|
Canada | CA$3.23 Million |
|
Konka Group Co Ltd
SHE:200016
|
China | HK$28.32 Billion |
Liability Composition Analysis (1996–2025)
This chart breaks down Champions Oncology Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see how much is Champions Oncology Inc worth.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.98 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 5.62 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.85 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Champions Oncology Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Champions Oncology Inc (1996–2025)
The table below shows the annual total liabilities of Champions Oncology Inc from 1996 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-04-30 | $28.57 Million | +1.92% |
| 2024-04-30 | $28.04 Million | -5.53% |
| 2023-04-30 | $29.68 Million | +12.91% |
| 2022-04-30 | $26.28 Million | +30.35% |
| 2021-04-30 | $20.16 Million | +28.82% |
| 2020-04-30 | $15.65 Million | +73.39% |
| 2019-04-30 | $9.03 Million | +11.40% |
| 2018-04-30 | $8.10 Million | +6.46% |
| 2017-04-30 | $7.61 Million | +37.41% |
| 2016-04-30 | $5.54 Million | +38.89% |
| 2015-04-30 | $3.99 Million | -29.66% |
| 2014-04-30 | $5.67 Million | +38.66% |
| 2013-04-30 | $4.09 Million | -66.48% |
| 2012-04-30 | $12.20 Million | -3.41% |
| 2011-04-30 | $12.63 Million | +436.35% |
| 2010-04-30 | $2.35 Million | -12.91% |
| 2009-04-30 | $2.70 Million | +166.70% |
| 2008-04-30 | $1.01 Million | +127.93% |
| 2007-04-30 | $444.82K | -33.71% |
| 2006-04-30 | $671.05K | +5.95% |
| 2005-04-30 | $633.34K | +30.69% |
| 2004-04-30 | $484.62K | -30.46% |
| 2003-04-30 | $696.91K | -11.86% |
| 2002-04-30 | $790.69K | +9.03% |
| 2001-04-30 | $725.18K | +38.19% |
| 2000-04-30 | $524.78K | +14.08% |
| 1999-04-30 | $460.00K | +17.95% |
| 1998-04-30 | $390.00K | +11.43% |
| 1997-04-30 | $350.00K | +12.90% |
| 1996-04-30 | $310.00K | -- |
About Champions Oncology Inc
Champions Oncology, Inc., a technology-enabled research company, provides technology solutions for drug discovery and development in the United States. The company, through its Tumorgraft technology platform, provides personalized cancer care based upon the implantation of human tumors in immune-deficient mice. It also offers translational oncology solutions that utilizes its technology platform … Read more